W
Wei Mao
Researcher at Guangzhou University of Chinese Medicine
Publications - 23
Citations - 273
Wei Mao is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Kidney disease & Tripterygium. The author has an hindex of 8, co-authored 23 publications receiving 157 citations.
Papers
More filters
Journal ArticleDOI
Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis.
La Zhang,La Zhang,Johannah Linda Shergis,Lihong Yang,Lihong Yang,Anthony Lin Zhang,Xinfeng Guo,Xinfeng Guo,Lei Zhang,Shuzhen Zhou,Lu Zeng,Wei Mao,Charlie Changli Xue,Charlie Changli Xue +13 more
TL;DR: The low quality of evidence suggested that adjunctive use of A. membranaceus preparations in addition to conventional therapies may be effective and tolerated for short-term reduction of albuminuria, proteinuria, and serum creatinine in DKD patients.
Journal ArticleDOI
Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials.
La Zhang,Lihong Yang,Johannah Linda Shergis,Lei Zhang,Anthony Lin Zhang,Xinfeng Guo,Xindong Qin,David W. Johnson,Xusheng Liu,Chuanjian Lu,Charlie Changli Xue,Wei Mao +11 more
TL;DR: Based on moderate to low quality evidence, CHM may have beneficial effects on renal function and albuminuria beyond that afforded by conventional treatment in adults with DKD.
Journal ArticleDOI
Traditional Medicines and Kidney Disease in Low- and Middle-Income Countries: Opportunities and Challenges.
John W. Stanifer,Kajiru Kilonzo,Daphne Wang,Guobin Su,Guobin Su,Wei Mao,Lei Zhang,La Zhang,La Zhang,Shobhana Nayak-Rao,J. Jaime Miranda +10 more
TL;DR: In the context of kidney diseases, the challenges and opportunities presented by traditional medicine practices are among the most important considerations for developing effective and sustainable public health strategies, especially concerning benefits and harms as mentioned in this paper.
Journal ArticleDOI
Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic Review.
Lei Zhang,Wei Mao,Xinfeng Guo,Yifan Wu,Chuang Li,Zhaoyu Lu,Guobin Su,Xiaoyan Li,Zhuangzhu Liu,Rong Guo,Xina Jie,Zehuai Wen,Xusheng Liu +12 more
TL;DR: Ginkgo biloba extract is a valuable drug which has prospect in treating early diabetic nephropathy, especially with high UAER baseline level, and the safety for early diabetic nephropathy is uncertain.
Journal ArticleDOI
Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB.
Tian Ruimin,Lijuan Wang,Aibin Chen,Lihua Huang,Liang Xing,Rongrong Wang,Wei Mao,Peng Xu,Peng Xu,Kun Bao +9 more
TL;DR: Results provide evidence that SQ exerts a novel therapeutic effect on MN via reducing proteinuria, ameliorating renal damage and restoring podocyte injuries, which are associated with the suppression of NFκB.